Evidence map›Paper›PMID 35511485›Full record

ArticleClinical and experimental immunology2022

Identification of ANXA2 on epithelial cells as a new receptor for secretory IgA using immunoprecipitation and mass spectrometry.

Shizuka Watanabe, Koichi Kobayashi, Maho Suzukawa, Sayaka Igarashi, Kazufumi Takada, Sahoko Imoto, Masashi Kitani, Takeshi Fukami, Takahide Nagase, Ken Ohta

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. SIgA in various pulmonary diseases.European journal of medical research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shizuka WatanabeClinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.ORCID 0000-0003-3012-826X
Koichi KobayashiClinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Maho SuzukawaClinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.ORCID 0000-0002-2265-1950
Sayaka IgarashiClinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Kazufumi TakadaClinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Sahoko ImotoClinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Masashi KitaniDepartment of Pathology, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Takeshi FukamiDepartment of Surgery, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Takahide NagaseDepartment of Respiratory Medicine, University of Tokyo, Tokyo, Japan.
Ken OhtaClinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Tokyo National Hospital · JPJapan Anti Tuberculosis Association · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secretory immunoglobulin A plays an important role in the protection against exogenous pathogens and antigens, but it has also been reported to have pathogenic potential. We previously found that secretory immunoglobulin A accumulated in the peripheral lungs during idiopathic pulmonary fibrosis and that transferrin receptor/CD71 was partially involved in secretory immunoglobulin A-induced inflammatory cytokine production in A549 cells. This study aimed to identify the receptor responsible for the induction of cytokine production by secretory immunoglobulin A-stimulated airway epithelial cells. To this end, immunoprecipitation followed by time-of-flight mass spectrometry and peptide mass fingerprinting were performed and Annexin A2 was detected as a novel receptor for secretory immunoglobulin A. Enzyme-linked immunosorbent assay demonstrated binding of secretory immunoglobulin A to Annexin A2, and flow cytometry showed robust expression of Annexin A2 on the surface of BEAS-2B cells, A549 cells, and normal human bronchial/tracheal epithelial cells. Experiments in A549 cells using Annexin A2 small interfering RNA and neutralizing antibodies suggested that Annexin A2 was partially involved in the production of interleukin-8/CXCL8 and C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 induced by secretory immunoglobulin A. Immunohistochemistry using lung sections revealed clear expression of Annexin A2 on airway epithelial cells, although the staining remained equivalent in idiopathic pulmonary fibrosis, asthma, and healthy control lungs. In conclusion, we identified that Annexin A2 expressed in airway epithelial cells is a novel receptor for secretory immunoglobulin A, which is involved in cytokine synthesis.

Indexed as

Annexin A2Idiopathic Pulmonary FibrosisCytokinesEpithelial CellsHumansImmunoglobulin A, SecretoryImmunoprecipitationLungMass SpectrometryAnnexin A2ANXA2 protein, humanCytokinesImmunoglobulin A, SecretoryAnnexin A2cytokineepithelial cellimmunoglobulin Areceptor

Identifiers

PMID35511485
PMCPMC9226145
OpenAlexW4229028133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.